课题基金 / 基金详情

Quantitative bioluminescence tomography for pre-clinical radiotherapy

Quantitative bioluminescence tomography for pre-clinical radiotherapy
用于临床前放射治疗的定量生物发光断层扫描
批准号:
10630901
负责人:
Ken Kang-Hsin Wang
金额:
$22.02万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-08-01 至 2025-05-31

项目摘要

项目成果

Ken Kang-Hsin Wang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Several groups, including ours, have initiated efforts to develop small-animal irradiators that mimic radiation therapy (RT) for human treatment. The major image modality used to guide irradiation is cone-beam CT (CBCT), and our CBCT-small animal radiation research platform (SARRP) was commercialized in 2010. Our system, and others, were transformative for pre-clinical RT research, and 115 machines are now in use world-wide by some 600 investigators. While CBCT provides excellent guidance capability, it is less adept at localizing soft tissue targets growing in a low image contrast environment. In contrast, bioluminescence imaging (BLI), provides strong image contrast and thus is an attractive solution for soft tissue targeting. However, commonly used 2D BLI on an animal surface is inadequate to guide irradiation, because optical transport from an internal bioluminescent tumor is highly susceptible to the effects of irregular torso and tissue optical properties. Recognition of these limitations led us to integrate 3D bioluminescence tomography (BLT) with SARRP. Our first BLT was designed to localize the center of mass (CoM) of an optical target for irradiation. This advance was received with much intrigue, however there was little practical adoption of the BLT system by SARRP users. It was clear that the investigators required two key unmet needs to be addressed, to significantly enhance their conduct of research: 1) knowledge of target shape is a fundamental need for RT. Without such information to guide radiation, large portions of normal tissue can be irradiated unnecessarily, leading to undesired experimental uncertainties. It is imperative that we advance BLT guidance beyond CoM, to a new and precise level of 3D target shape delineation; and 2) clinical practice recognizes the importance of complementary use of functional and anatomical image for RT. BLI measures cellular viability, thus it is an ideal imaging modality for longitudinally monitoring treatment outcome. However, the quantitative information that surface BLI provides for assessment is currently limited or even inaccurate. With the novel reconstruction algorithm and calibration methods proposed in this application, we will establish a new quantitative BLT (QBLT) to address this need. We hypothesize that the QBLT/CBCT-guided small animal radiation system will provide investigators new capabilities to localize soft tissue target, define its shape for conformal irradiation, and non-invasively quantify treatment outcome. Our aims are: Aim 1: design and construct a standalone QBLT system readily adapted to commercial radiation platform; Aim 2: optimize input data, and develop calibration method and reconstruction algorithm for target shape delineation and quantitative imaging; Aim 3: validate the QBLT-guided RT in vivo and assess its suitability for treatment assessment. The success of this proposal will significantly enhance small animal radiotherapy research with the capabilities of functional targeting and assessment beyond anatomical imaging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
X-ray/optical tomographic guidance and assessment for pre-clinical radiation Research
  • 批准号:
    10302256
  • 项目类别:
  • 资助金额:
    $24.66万
  • 财政年份:
    2021
  • 负责人:
    Ken Kang-Hsin Wang
  • 依托单位:
X-ray/optical tomographic guidance and assessment for pre-clinical radiation Research
  • 批准号:
    10684628
  • 项目类别:
  • 资助金额:
    $35.28万
  • 财政年份:
    2021
  • 负责人:
    Ken Kang-Hsin Wang
  • 依托单位:
Quantitative bioluminescence tomography for pre-clinical radiotherapy
  • 批准号:
    10302251
  • 项目类别:
  • 资助金额:
    $29.1万
  • 财政年份:
    2019
  • 负责人:
    Ken Kang-Hsin Wang
  • 依托单位:
A pre-clinical x-ray/optical tomography-guided radiation research platform for pancreatic cancer
  • 批准号:
    10302945
  • 项目类别:
  • 资助金额:
    $1.83万
  • 财政年份:
    2018
  • 负责人:
    Ken Kang-Hsin Wang
  • 依托单位:
海外基金